Glaucoma News

Researchers have identified significant associations between intracranial pressure, translaminar pressure difference and visual field parameters in patients with normal-tension glaucoma, according to a study published in Diagnostics.

In this Healio Video Perspective from the EnVision Summit, Constance O. Okeke, MD, MSCE, discusses the mechanism of action and efficacy of Vyzulta to treat glaucoma.

Glaukos submitted a new drug application to the FDA for the iDose TR, a microinvasive intraocular implant designed to continuously deliver a travoprost formulation for the treatment of glaucoma.

TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, Robert J. Noecker, MD, MBA, discusses advantages that the TrabEx Pro offers for performing goniotomy.

Visionix USA has launched its new high-speed, multimodal Optovue Solix FullRange OCT system in North America, the company announced in a press release.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Joel M. Solano, MD, CEO of eyecbetter, discusses offerings from the company.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, discusses study results for QLS-111.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Malik Y. Kahook, MD, discusses study data investigating the Spyglass drug delivery platform, which offers sustained delivery of bimatoprost.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Courtney Bovee, MD, discusses developments in the glaucoma field, including innovative surgical techniques and sustained-release drug delivery.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Savas Komban, CEO and co-founder of Smartlens, discusses developments in unmet needs in glaucoma, including IOP assessment.